Teva Pharmaceutical Industries Limited

WHO'M
ai
Digital Profiler. Simply click the AI button
CUSIP
881624209
SEDOL
2883878
CIK
0000818686
www.tevapharm.com
LEI:
©
FIGI: BBG000C0CD58
TEVA
Teva Pharmaceutical Industries Limited
GICS: - · Sector: Healthcare · Sub-Sector: Drug Manufacturers - Specialty & Generic
NAME
Teva Pharmaceutical Industries Limited
ISIN
US8816242098
TICKER
TEVA
MIC
XNYS
REUTERS
TEVA.N
BLOOMBERG
TEVA US
BUILD THEMEFOLIO SHARE IDEAS DISCUSS
LEVERAGE INVEST
EN 728x90
Financial Intelligence
360° iHub Crowd iFeed ATH Tracker Index Tracker ETF TF Spicy2 X-Billboard
FOR INVESTORS
FOR TRADERS
Securities Trading Warrants
TradingView ActivTrader MT4 MT5

GlobeNewswire is an important news source that provides investors with company-related information. In particular, it deals with events that may be relevant to the listing of companies or tradable financial instruments. You can access the complete overview of all reports via this link.

Wed, 11.09.2024

TEL AVIV, Israel, Sept. 11, 2024 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that Richard Francis, Teva's President and CEO, will present at the Bank of America 2024 Global Healthcare Conference on Thursday, September 19, 2024. The presentation will begin at 8.15 A.M. British summer time (3.15 A.M. Eastern Time).

Research & Analysis
Read more
Mon, 26.08.2024

TEL AVIV, Israel, Aug. 26, 2024 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that Richard Francis, Teva's President and CEO, will present at the Morgan Stanley 22nd Annual Global Healthcare Conference on Wednesday, September 4, 2024. The presentation will begin at 11:30 A.M. Eastern Time.

Research & Analysis
Read more
Wed, 31.07.2024

For an accessible version of this Press Release, please visit www.tevapharm.com

Research & Analysis
Read more
We are different
OPEN FINANCIAL
DATA & KNOWLEDGE HUB
We make the difference
Information on product placements